SkinLabo is an innovative skincare brand established in 2016, quickly gaining traction as a preferred choice for over 2 million customers across more than 20 countries, including Europe and the United States. With a commitment to catering to individual skin needs, it offers customized, laboratory-based treatments.
Known for combining deep scientific knowledge with an understanding of skin requirements, SkinLabo collaborates with top-tier Italian Research and Innovation Partner Laboratories. Its formulations prioritize efficacy using essential ingredients. The brand emphasizes sustainability, maintaining a 100% Made in Italy production approach, and adheres to Cruelty Free, Plastic Neutral, and Carbon Neutral delivery practices.
Headquartered in Italy, SkinLabo operates in the Consumer Goods, E-Commerce, Health Care, and Wellness Beauty sectors. It received a €6.00M Series B investment from 8a + INVESTMENTS on January 10, 2022. This strategic injection is pivotal as they scale operations in competitive markets.